Optimi Health Corp. (OPTH) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Optimi Health Corp. $0.56, price $4.49, upside -87.5%, quality 26 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Optimi Health Corp. Common Shares for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $3.03 – $23.74 · fair‑value band $0.4100 – $0.8300 · the $4.49 price screens above the $0.5600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Optimi Health Corp. Common Shares in your weekly email
Every Wednesday you see whether Optimi Health Corp. Common Shares is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.
Show more
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Stock analysis
Optimi Health Corp. Common Shares (OPTH) currently trades at $4.49, while our model-based Fair Value estimate is $0.5600, 87.5% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 91/100, which puts the evidence level at low.
Scenario range: $0.4100 (bear) to $0.8300 (bull), the price of $4.49 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 26/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Optimi Health Corp. Common Shares reported revenue of C$427K in FY2025 versus C$80.7K in FY2022, a compound +74.2%/yr. Reported net income was −C$3.7M in FY2025.
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).
What moves the price
The share trades about 48% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at −88%, OPTH screens richer than that median.
Fair Value models
Bear $0.4100Fair Value $0.5600Bull $0.8300
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+9.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+74.2%
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−8,219.5% (2022) → −1,062.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Optimi Health Corp. Common Shares with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 599 stocks
Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score27 · Bottom 25%
Fair Value upside−87.9% · Bottom 25%
Profitability
Return on assets−20.3% · Bottom 25%
Growth and dividend
Revenue growth62.5% · Top 25%
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/B4.31× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 17
FUTURE (revenue growth)100· sector 24
PAST (return on equity)0· sector 27
HEALTH (low debt)0· sector 96
DIVIDEND (yield)0· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Optimi Health Corp. Common Shares Fair Value". https://www.fairvalue-calculator.com/stock/OPTH
Frequently asked questions
Is Optimi Health Corp. (OPTH) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.5600 versus a price of $4.49, about −88% upside (overvalued).
What is the fair value of OPTH?
Our model-based fair value for Optimi Health Corp. Common Shares is $0.5600 (as of Sep 24, 2026), built from audited fundamentals. The current price: $4.49.
What is the quality score of OPTH?
Optimi Health Corp. Common Shares has a Quality Score of 26/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Optimi Health Corp. (OPTH)?
Our model-based price target is the fair value of $0.5600 (as of Sep 24, 2026) from 1 valuation models. Cautious scenario $0.4100, optimistic scenario $0.8300. It is a calculation from audited fundamentals, not an analyst target.
What is the Optimi Health Corp. Common Shares stock forecast for 2026?
Our models put fair value at $0.5600, about −88% upside versus a price of $4.49 (overvalued). Cautious scenario $0.4100, optimistic scenario $0.8300. The calculation is refreshed regularly with new filings.
What is the revenue of Optimi Health Corp. (OPTH)?
Optimi Health Corp. Common Shares reported trailing-twelve-month revenue of about C$232K (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Optimi Health Corp. (OPTH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Optimi Health Corp. Common Shares it is $0.5600 per share (as of Sep 24, 2026), against a price of $4.49. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Optimi Health Corp. Common Shares stock overvalued or undervalued in 2026?
As of Sep 24, 2026, OPTH trades above its calculated fair value: price $4.49, fair value $0.5600, a gap of about −88% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OPTH?
No. The price is what the market pays today ($4.49); the fair value is what the company's own numbers justify ($0.5600). For Optimi Health Corp. Common Shares the two are $3.93 per share apart. That gap is exactly why we show both numbers side by side.
How much is Optimi Health Corp. Common Shares worth?
The market values Optimi Health Corp. Common Shares at about $28.3M (market capitalisation, as of Sep 24, 2026). Per share that is $4.49; our models calculate a fair value of $0.5600 per share.
What do the bullish and bearish scenarios say about OPTH?
Our models span a range for Optimi Health Corp. Common Shares: cautious scenario $0.4100, base $0.5600, optimistic $0.8300 per share (as of Sep 24, 2026, price $4.49). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Optimi Health Corp. (OPTH)?
Balance-sheet figures for Optimi Health Corp. Common Shares (as of Sep 24, 2026): return on equity −88.7%. They feed the Quality Score of 26/100, which measures business quality independently of the share price.
How far is OPTH from its 52-week high?
Optimi Health Corp. Common Shares trades at $4.49, about 48% below its 52-week high of $8.61 and 12% above the low of $4.01 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $0.5600 is for.
Which stocks are comparable to Optimi Health Corp. Common Shares?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Optimi Health Corp. Common Shares stock attractive at the current price?
The data as of Sep 24, 2026: price $4.49, calculated fair value $0.5600 (−88%), Quality Score 26/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of OPTH calculated?
We run Optimi Health Corp. Common Shares through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.5600, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Optimi Health Corp. Common Shares itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Optimi Health Corp. (OPTH)?
The closing price on Oct 2, 2026 was $4.49. Our model-based fair value is $0.5600, about −88% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Optimi Health Corp. Common Shares right now?
The price sits above even our optimistic bull case ($0.8300). The favourable scenario is already priced in. Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.4100 to $0.8300) leaves room in how you read the outcome.
Key figures of Optimi Health Corp. Common Shares
How large is the market capitalisation of Optimi Health Corp. (OPTH)?
The market capitalisation of Optimi Health Corp. Common Shares is $28.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Optimi Health Corp. (OPTH)?
Earnings per share at Optimi Health Corp. Common Shares are $−1.21. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Optimi Health Corp. (OPTH)?
The return on equity (ROE) of Optimi Health Corp. Common Shares is −88.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Optimi Health Corp. (OPTH)?
On an EBIT basis the return on assets of Optimi Health Corp. Common Shares is −31.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Optimi Health Corp. (OPTH)?
The operating margin of Optimi Health Corp. Common Shares is −1,034% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Optimi Health Corp. (OPTH)?
Revenue at Optimi Health Corp. Common Shares is growing +62.5% versus a year earlier (3y avg +74.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Optimi Health Corp. (OPTH) generate?
The free cash flow of Optimi Health Corp. Common Shares is −C$2.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Optimi Health Corp. (OPTH) carry?
The net debt of Optimi Health Corp. Common Shares is C$5.5M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Optimi Health Corp. Common Shares in the live analysis
One click puts Optimi Health Corp. Common Shares on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 24, 2026